Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists. [PDF]
Berger T+12 more
europepmc +1 more source
Ensuring Sustainability in Pharmaceutical Care: A Retrospective Analysis of Administrative Databases on the Utilization, Costs, and Switching Patterns of Biological Therapies in the Agency for Health Protection of the Metropolitan Area of Milan. [PDF]
Langfelder RMB+4 more
europepmc +1 more source
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. [PDF]
Fiorino G+7 more
europepmc +1 more source
Biosimilars: Current regulatory perspective and challenges
Diwakar Jha+2 more
openalex +1 more source
Dose Tapering of Advanced Therapies in Psoriatic Arthritis: Clinical Predictors and Outcomes in a Biosimilar-Dominant Real-Life Cohort. [PDF]
Loredo M+5 more
europepmc +1 more source
What role for real-world evidence in market access of biosimilars? [PDF]
Simoens S, Lockhart CM, Courmier DF.
europepmc +1 more source
A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs. [PDF]
Dimmito MP+10 more
europepmc +1 more source
Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. [PDF]
Aljuhani HS+7 more
europepmc +1 more source
Anti-Adalimumab Antibodies Purified from Juvenile Idiopathic Arthritis Patients: Kinetic Characterization Among Biosimilars. [PDF]
Di Santo A+8 more
europepmc +1 more source